Patents by Inventor Michel Hamon

Michel Hamon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10813891
    Abstract: The use of tapentadol in the treatment of pain and/or pain chronification in a subject suffering from pain chronification and/or in the treatment of pain and inhibition of pain chronification in a subject suffering from pain and at risk of pain chronification, as well as the use of tapentadol for the treatment or inhibition of migraine.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: October 27, 2020
    Assignee: GrĂ¼nenthal GmbH
    Inventors: Klaus Schiene, Ilona Steigerwald, Michel Hamon, Johannes Schneider, Silvia Reinartz, Ulrich Jahnel, Thomas Tzschentke
  • Publication number: 20200009083
    Abstract: The use of tapentadol in the treatment of pain and/or pain chronification in a subject suffering from pain chronification and/or in the treatment of pain and inhibition of pain chronification in a subject suffering from pain and at risk of pain chronification, as well as the use of tapentadol for the treatment or inhibition of migraine.
    Type: Application
    Filed: July 19, 2019
    Publication date: January 9, 2020
    Applicant: GrĂ¼nenthal GmbH
    Inventors: Klaus SCHIENE, Ilona STEIGERWALD, Michel HAMON, Johannes SCHNEIDER, Silvia REINARTZ, Ulrich JAHNEL, Thomas TZSCHENTKE
  • Publication number: 20190274974
    Abstract: The use of tapentadol for the treatment of pain associated with disorders of the trigeminal nerve, in particular for use in the treatment of pain associated with trigeminal neuralgia.
    Type: Application
    Filed: May 28, 2019
    Publication date: September 12, 2019
    Applicant: GRUENENTHAL GMBH
    Inventors: Thomas CHRISTOPH, Jean De Vry, Thomas Tzschentke, Petra Bloms-Funke, Klaus Schiene, Michel Hamon
  • Patent number: 10398657
    Abstract: The use of tapentadol in the treatment of pain and/or pain chronification in a subject suffering from pain chronification and/or in the treatment of pain and inhibition of pain chronification in a subject suffering from pain and at risk of pain chronification, as well as the use of tapentadol for the treatment or inhibition of migraine.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: September 3, 2019
    Assignee: GRUENENTHAL GMBH
    Inventors: Klaus Schiene, Ilona Steigerwald, Michel Hamon, Johannes Schneider, Silvia Reinartz, Ulrich Jahnel, Thomas Tzschentke
  • Publication number: 20160354324
    Abstract: The use of tapentadol in the treatment of pain and/or pain chronification in a subject suffering from pain chronification and/or in the treatment of pain and inhibition of pain chronification in a subject suffering from pain and at risk of pain chronification, as well as the use of tapentadol for the treatment or inhibition of migraine.
    Type: Application
    Filed: August 22, 2016
    Publication date: December 8, 2016
    Inventors: Klaus SCHIENE, Ilona STEIGERWALD, Michel HAMON, Johannes SCHNEIDER, Silvia REINARTZ, Ulrich JAHNEL, Thomas TZSCHENTKE
  • Patent number: 8864419
    Abstract: A foundation system for supporting an offshore wind energy convertor is provided and includes a foundation base resting on the seabed and a column supporting the wind energy convertor which is linked to the foundation base. The column and the base are linked by an articulated joint connection, allowing tilt motions of the column in all directions from a vertical axis. A wind power generator facility including such a support, and a method of erecting such a foundation system, are also provided.
    Type: Grant
    Filed: October 18, 2011
    Date of Patent: October 21, 2014
    Assignees: Marine Engineering Energy Solutions, Ltd.
    Inventors: Peter Broughton, Richard Davies, Peter Martin, Michel Hamon, Nicolas Parsloe
  • Publication number: 20120309840
    Abstract: The use of tapentadol for the treatment of pain associated with disorders of the trigeminal nerve, in particular for use in the treatment of pain associated with trigeminal neuralgia.
    Type: Application
    Filed: April 3, 2012
    Publication date: December 6, 2012
    Applicant: Gruenenthal GmbH
    Inventors: Thomas CHRISTOPH, Jean De Vry, Thomas Tzschentke, Petra Bloms-Funke, Klaus Schiene, Michel Hamon
  • Publication number: 20120309841
    Abstract: The use of tapentadol in the treatment of pain and/or pain chronification in a subject suffering from pain chronification and/or in the treatment of pain and inhibition of pain chronification in a subject suffering from pain and at risk of pain chronification, as well as the use of tapentadol for the treatment or inhibition of migraine.
    Type: Application
    Filed: April 3, 2012
    Publication date: December 6, 2012
    Applicant: Gruenenthal GmbH
    Inventors: Klaus Schiene, IIona Steigerwald, Michel Hamon, Johannes Schneider, Silvia Reinartz, Ulrich Jahnel, Thomas Tzschentke
  • Publication number: 20120093589
    Abstract: A foundation system for supporting an offshore wind energy convertor is provided and includes a foundation base resting on the seabed and a column supporting the wind energy convertor which is linked to the foundation base. The column and the base are linked by an articulated joint connection, allowing tilt motions of the column in all directions from a vertical axis. A wind power generator facility including such a support, and a method of erecting such a foundation system, are also provided.
    Type: Application
    Filed: October 18, 2011
    Publication date: April 19, 2012
    Inventors: Peter Broughton, Richard Davies, Peter Martin, Michel Hamon, Nicolas Parsloe
  • Publication number: 20100075992
    Abstract: The present invention refers to the use of a sodium channel blocker such as tetrodotoxin or saxitoxin, their analogues and derivatives as well as their physiologically acceptable salts, in medicinal products for human therapeutics for the treatment of peripheral-nervously derived neuropathic pain.
    Type: Application
    Filed: September 20, 2005
    Publication date: March 25, 2010
    Applicant: LABORATORIOS DEL DR. ESTEVE S.A.
    Inventors: Helmut Buschmann, Frank Hay Kong Shum, Kim Noel Fisher, Anh Ho Ngoc, Michel Hamon
  • Publication number: 20090143415
    Abstract: The present invention refers to the use of a sodium channel blocker such as tetrodotoxin or saxitoxin, their analogues and derivatives as well as their physiologically acceptable salts, in medicinal products for human therapeutics for the treatment of central-nervously derived neuropathic pain.
    Type: Application
    Filed: September 21, 2005
    Publication date: June 4, 2009
    Applicant: Wex Pharmaceuticals, Inc.
    Inventors: Helmut Heinrich Buschmann, Frank Hay Kong Shum, Kim Noel Fisher, Anh Ho Ngoc, Michel Hamon